Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know

Company Overview - Mesoblast Limited (MESO) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to the market [3] Price Performance - MESO shares have increased by 40.59% over the past week, while the Zacks Medical - Biomedical and Genetics industry remained flat during the same period [5] - Over the past month, MESO's price change is 44.19%, significantly outperforming the industry's 6.79% [5] - In the last quarter, MESO shares rose by 28.34%, and over the past year, they gained 94.04%, compared to the S&P 500's increases of 22.7% and 15.9%, respectively [6] Trading Volume - The average 20-day trading volume for MESO is 302,528 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for MESO has been revised upward, while none have been revised downward, improving the consensus estimate from -$0.45 to -$0.36 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions [9] Conclusion - Considering the strong momentum indicators and positive earnings outlook, MESO is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]